Testicular granulosa cell tumors: Rare tumors need to be studied too

ONCOLOGY

Volumn 23, Issue 9, 2009, Pages

  Bosl, George J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; PAZOPANIB; VASCULOTROPIN RECEPTOR;

ANTIANGIOGENIC THERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; GRANULOSA CELL TUMOR; HUMAN; OVARY CANCER; RETROPERITONEAL CANCER; TESTIS CANCER;

EID: 70349272969     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Schumer ST, Cannistra SA: Granulosa cell tumor of the ovary. J Clin Oncol 15:1180-1189, 2003.
2. Harrison MR, Huang W, Liu G, et al: Response to antiangiogenesis therapy in a patient with advanced adult-type testicular granulosa cell tumor. Oncology (Williston Park) 23:792-795, 2009.
3. Kumar R, Knick VB, Rudolph SK, et al: Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity. Mol Cancer Ther 6:20122021, 2007. (Pubitemid 47052491)
4. Hurwitz HJ, Dowlati A, Saini S, et al: Phase/I trial of pazopanib in patients with advanced cancer. Clin Cancer Res 15:4220-4227, 2009.
5. Davis JS, Rueda BR, Spanel-Borowski K: Microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 1:89, 2003.
6. Reynolds LP, Grazul-Bilska AT, Redmer DA: Angiogenesis in the corpus luteum. Endocrine 1:1-9, 2000.
7. Tao X, Sood AK, Deavers MT, et al: Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors. Gynecol Oncol June 12, 2009 (epub ahead of print).